BRCA2 ‐Related Hereditary Cancer Syndrome‐Associated Small Bowel Adenocarcinoma With Multiple BRCA2 Mutations: A Case Report and Review of the Literature
Cancer Reports · 2025
DOI: 10.1002/cnr2.70200 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cancer Reports, 2025. Verfasst von Francesca Antoci und 12 weiteren Autor:innen. Beteiligte Einrichtung: Anatomic Pathology Unit, IRCCS San Matteo Hospital Foundation, Pavia, Italy. Hauptthemen laut MEDLINE: Adenocarcinoma, BRCA2 Protein, Duodenal Neoplasms, Intestinal Neoplasms. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Small bowel adenocarcinomas (SBAs) are rare and aggressive cancers. About one‐fifth of SBA patients have predisposing conditions; among them, there are also genetic tumor syndromes, including Lynch syndrome, familial adenomatous polyposis, and Peutz‐Jeghers syndrome. Although BRCA2 mutations, both somatic and germline, have been recently described in SBAs, direct evidence of BRCA2 inactivation in SBA tumor tissue of patients with BRCA2 ‐related hereditary cancer syndrome is still very limited. Case Presentation Herein, we described a case of a 51‐year‐old woman with a history of breast cancer who developed an adenocarcinoma of the duodeno‐jejunal flexure causing persistent vomiting. After clinical staging, the patient underwent surgical resection, and histologic examination of the specimen confirmed a poorly differentiated adenocarcinoma infiltrating the visceral peritoneum and showing lymph node metastases (stage III, pT4N1). Two years later, the SBA relapsed, and next generation sequencing was performed in matched tumor and normal tissues. In addition to KRAS and TP53 mutations in the tumor, both somatic and germline BRCA2 mutations were identified, indicating biallelic BRCA2 alterations.
Conclusion
BRCA2 ‐associated hereditary tumor syndrome could have an etio‐pathogenetic role in SBA development; thus, we suggest that this syndrome should be considered in patients with an SBA diagnosis below the age of 50 years, especially when a personal or family history of breast cancer is present.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Anatomic Pathology Unit, IRCCS San Matteo Hospital Foundation, Pavia, Italy.
- University of Pavia, Pavia, Italy.
- Unit of Pathology, Department of Surgery ASL BI, Nuovo Ospedale Degli Infermi, Ponderano, Italy.
- Anatomic Pathology Unit, Department of Molecular Medicine, University of Pavia, Pavia, Italy.
- Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
- Unit of Pathology, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.
ORCID-Profile: Alessandro Vanoli
Zitieren
APA
Antoci, F., Colella, T., Biletta, E., Travaglino, E., De Lisi, G., Quaquarini, E., Arpa, G., Pisacane, A. M., Paris, M. K., Corallo, S., Di Sabatino, A., Leone, F., & Vanoli, A. (2025). BRCA2 ‐Related Hereditary Cancer Syndrome‐Associated Small Bowel Adenocarcinoma With Multiple BRCA2 Mutations: A Case Report and Review of the Literature. Cancer Reports. https://doi.org/10.1002/cnr2.70200
Vancouver
Antoci F, Colella T, Biletta E, Travaglino E, De Lisi G, Quaquarini E, et al. BRCA2 ‐Related Hereditary Cancer Syndrome‐Associated Small Bowel Adenocarcinoma With Multiple BRCA2 Mutations: A Case Report and Review of the Literature. Cancer Reports. 2025. doi:10.1002/cnr2.70200
BibTeX
@article{Antoci2025,
author = {Antoci, Francesca and Colella, Tommaso and Biletta, Elena and Travaglino, Erica and De Lisi, Giuseppe and Quaquarini, Erica and Arpa, Giovanni and Pisacane, Alberto Maria and Paris, Myriam Katja and Corallo, Salvatore and Di Sabatino, Antonio and Leone, Francesco and Vanoli, Alessandro},
title = {BRCA2 ‐Related Hereditary Cancer Syndrome‐Associated Small Bowel Adenocarcinoma With Multiple BRCA2 Mutations: A Case Report and Review of the Literature},
journal = {Cancer Reports},
year = {2025},
doi = {10.1002/cnr2.70200}
}
EUVIMED